• Medical_Professionals
• Medical_students
• Nurses

OMICS International is conducting its “Annual Conference on H1N1 & Influenza Vaccines “during December 01-02, 2016 at Atlanta, USA. The conference highlights the theme “Advanced Technologies and Current Research in the field of H1N1 & Influenza Vaccines”. H1N1 Influenza Vaccines 2016 takes an initiative to provide health practitioners an understanding about the vital role of H1N1 Influenza vaccines 2016 in health and healing. The conference also includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Influenza is a major respiratory pathogen causing annual outbreaks and occasional pandemics. Influenza vaccination is the major method of prophylaxis. Currently annual influenza vaccination is recommended for groups at high risk of complications from influenza infection such as pregnant women, young children, people with underlying disease and the elderly, along with occupational groups such as healthcare workers and farm workers. There are two main types of vaccines available: the parenteral inactivated influenza vaccine and the intranasal live attenuated influenza vaccine. Influenza continues to remain among the most important respiratory infections causing annual seasonal epidemics and the occasional pandemic. The 2009 H1N1 flu virus (referred to as “swine flu “early on) is a new influenza virus strain that is causing illness in people. This new virus strain was first detected in people in the US in April 2009 and is spreading from person-to-person worldwide, probably in much the same way that regular seasonal influenza viruses spread. On June 11, 2009, the World Health Organization (WHO) declared that a pandemic of 2009 H1N1 flu was underway. On September 15, 2009, FDA approved four Influenza A (H1N1) 2009 Monovalent Vaccines for the active immunization of individuals against influenza disease caused by pandemic (H1N1) 2009 virus.

Why to Attend??

H1N1 Influenza Vaccines 2016 takes an initiative to provide health practitioners an understanding about the vital role of H1N1 Influenza vaccines in health and healing. H1N1 Influenza Vaccines 2016 is aimed to provide a distinguished opportunity to the professionals in the field of virology and vaccines to discuss latest research and challenges in the field. H1N1 Influenza Vaccines 2016 is designed to provide an exclusive platform for Virologist, Scientists, and other health-care professionals, researchers and students working in the field to deliberately, exchange views and their experiences in front of a large international audience. H1N1 Influenza Vaccines 2016 welcomes Presidents, CEO’s, Scientists and Researchers in Viruses and Vaccines sectors, Delegates and industrial executives from pharmaceuticals and healthcare industries to participate in the interactive scientific-sessions, B2B meetings and panel discussions. The companies dealing with H1N1 Influenza vaccines medication and supplements can exhibit their products in the H1N1 Influenza Vaccines 2016 exhibition and expo.

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Drop us an email for Program enquiry.

h1n1influenza@insightconferences.com

Drop us an email for Program enquiry.

h1n1influenza@insightconferences.com